Drug Approval | July 02, 2022
Ascentage Pharma gets IND clearance by the US FDA for novel EED Inhibitor APG-5918
This multicenter, open-label Phase I study is designed to assess the safety and tolerability
This multicenter, open-label Phase I study is designed to assess the safety and tolerability
73% have cited fears like losing eyesight, painful procedure or long recovery period when it comes to cataract surgeries
Dr. Rizo brings extensive industry leadership experience to Vividion, having held multiple senior executive roles during her career at both biotechnology and large pharmaceutical companies.
This new €59 million, 70,000 square foot facility, officially opened today, brings 50 new jobs to the area
The array available for a subscription includes popular products to make menstrual hygiene a regular practice and extend further affordability to its users
This is the first Agilent lab to receive the My Green Lab Certification and plans are under way to certify additional labs.
With $120m jointly invested in the newly-formed initiative, and with other strategic investors expected to join, the venture will develop an alternative, plant-based ingredient using biotechnology
Revenues from operations for the full year ended March 31, 2022 stood at Rs. 590.05 crore as compared to Rs. 449.82 crore in FY21
We see significant potential in working with oncolytic virus companies and Neo antigen-companies
Becomes the first airline globally to develop and launch sustainable, temperature-controlled containers for the transportation of pharmaceuticals
Subscribe To Our Newsletter & Stay Updated
